Alnylam Pharmaceuticals
ALNY
#584
Rank
HK$274.08 B
Marketcap
HK$2,135
Share price
-0.89%
Change (1 day)
55.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of June 2024 : HK$20.45 B

According to Alnylam Pharmaceuticals 's latest financial reports the company has HK$20.45 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$19.05 B11.22%
2022-12-31HK$17.12 B-9.8%
2021-12-31HK$18.99 B30.67%
2020-12-31HK$14.53 B21.47%
2019-12-31HK$11.96 B40.94%
2018-12-31HK$8.48 B-35.73%
2017-12-31HK$13.20 B171.75%
2016-12-31HK$4.86 B-41.96%
2015-12-31HK$8.37 B54.93%
2014-12-31HK$5.40 B183.5%
2013-12-31HK$1.90 B100.29%
2012-12-31HK$0.95 B-16.28%
2011-12-31HK$1.13 B-37.31%
2010-12-31HK$1.81 B-16.88%
2009-12-31HK$2.18 B-34.58%
2008-12-31HK$3.33 B9.6%
2007-12-31HK$3.04 B80.11%
2006-12-31HK$1.68 B172.42%
2005-12-31HK$0.62 B92.43%
2004-12-31HK$0.32 B79.01%
2003-12-31HK$0.18 B49.17%
2002-12-31HK$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$3.38 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$76.46 B 273.73%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.38 B-44.36%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.31 B-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.73 B-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$65.75 B 221.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$56.78 B 177.53%๐Ÿ‡ซ๐Ÿ‡ท France
HK$17.60 B-13.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel